OcuTerra Therapeutics

Boston, United States

OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.

Jan 2024

Convertible Note

Biotechnology Therapeutics

Top Investors

Robin Hood Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OcuTerra Therapeutics

Who are OcuTerra Therapeutics's investors?

OcuTerra Therapeutics's investors include Robin Hood Ventures.

Where is OcuTerra Therapeutics headquartered?

OcuTerra Therapeutics is headquartered in Boston, United States.

What does OcuTerra Therapeutics do?

OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.

What stage is OcuTerra Therapeutics at?

OcuTerra Therapeutics is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 10, 2024.

MLA

"OcuTerra Therapeutics — Funding & Investors." VCBacked, January 10, 2024, https://www.vcbacked.co/company/ocuterra-therapeutics. Accessed July 5, 2026.

APA

VCBacked. (2024). OcuTerra Therapeutics — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/ocuterra-therapeutics

Wikipedia (cite web)

{{cite web |title=OcuTerra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ocuterra-therapeutics |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 10, 2024.